Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO [Yahoo! Finance]
Medline Inc. - Class A common stock (MDLN)
Company Research
Source: Yahoo! Finance
Medline Inc. (NASDAQ: MDLN ) is one of the best NASDAQ stocks to buy according to hedge funds . On February 25, Medline reported its Q4 and full-year 2025 financial results, marking a significant year that included the completion of its initial public offering. For Q4, the company achieved net sales of $7.8 billion, representing a 14.8% increase driven by higher volumes in the Medline Brand and Supply Chain Solutions segments. However, net income for the quarter fell by 37.7% to $180 million, while Adjusted EBITDA remained nearly flat at $805 million, impacted by higher operating costs, IPO-related expenses, and tariff-related costs of goods sold. The full year results showed a 11.5% increase in net sales to $28.4 billion, supported by $2.4 billion in new customer signings. While net income for the year decreased slightly by 3.6% to $1.2 billion due to investments in headcount and tariffs, Adjusted EBITDA grew by 3.2% to $3.5 billion. Looking ahead, the CEO emphasized that the tr
Show less
Read more
Impact Snapshot
Event Time:
MDLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDLN alerts
High impacting Medline Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MDLN
News
- Medline (MDLN) is now covered by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "hold (c-)" rating on the stock.MarketBeat
- Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, TexasPR Newswire
- Medline (MDLN) is now covered by Citigroup Inc.. They set a "buy" rating and a $60.00 price target on the stock.MarketBeat
- Medline (MDLN) had its price target raised by JPMorgan Chase & Co. from $50.00 to $53.00. They now have an "overweight" rating on the stock.MarketBeat
- Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional sharesGlobeNewswire
MDLN
Earnings
- 2/25/26 - Miss
MDLN
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- MDLN's page on the SEC website